SUTIMLIMAB-JOME

321 reported adverse events

Drug classes: Classical Complement Pathway Inhibitor [EPC]

These side effects are most commonly reported by patients taking SUTIMLIMAB-JOME:

# Side effect Count
0 OFF LABEL USE 39
1 HAEMOGLOBIN DECREASED 23
2 ARTHRALGIA 20
3 FATIGUE 18
4 DEATH 16
5 HAEMOLYSIS 16
6 CONDITION AGGRAVATED 15
7 DRUG INEFFECTIVE 13
8 HEADACHE 13
9 COVID-19 12
See all common reactions for SUTIMLIMAB-JOME

SUTIMLIMAB-JOME is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 B-CELL MALIGNANCY 1 0.5000
1 CELLULITIS PASTEURELLA 1 0.2500
2 WHITE BLOOD CELL AGGLUTINATION PRESENT 1 0.0833
3 LIGHT CHAIN ANALYSIS 1 0.0417
4 RED BLOOD CELL AGGLUTINATION 1 0.0263
5 DEVICE MATERIAL OPACIFICATION 1 0.0222
6 TRAUMATIC SUBARACHNOID HAEMORRHAGE 1 0.0156
7 BURSA INJURY 1 0.0154
8 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 4 0.0110
9 COLD TYPE HAEMOLYTIC ANAEMIA 2 0.0085
See all enriched reactions for SUTIMLIMAB-JOME